The latest price target for Trulieve Cannabis (OTCQX:TCNNF) was reported by Needham on August 6, 2024. The analyst firm set a price target for $14.50 expecting TCNNF to rise to within 12 months (a possible 21.04% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Trulieve Cannabis (OTCQX:TCNNF) was provided by Needham, and Trulieve Cannabis reiterated their buy rating.

There is no last upgrade for Trulieve Cannabis

There is no last downgrade for Trulieve Cannabis.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Trulieve Cannabis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Trulieve Cannabis was filed on August 6, 2024 so you should expect the next rating to be made available sometime around August 6, 2025.

While ratings are subjective and will change, the latest Trulieve Cannabis (TCNNF) rating was a reiterated with a price target of $14.50 to $14.50. The current price Trulieve Cannabis (TCNNF) is trading at is $11.98, which is out of the analyst’s predicted range.